BREAKING
NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago NVIDIA (NVDA) eyes China AI chip re-entry as export licensing shifts to case-by-case review 3 days ago Qualcomm (QCOM) authorizes $20B stock repurchase program, raises quarterly dividend to $0.92 3 days ago UP Fintech Holding Limited Reports Strong 2025 Results 3 days ago FedEx (FDX) Q3 Earnings Crush Estimates: EPS of $5.25 Beats by 27% on $24B Revenue 3 days ago Cato Corporation 2025 Financial Results Summary 3 days ago GROY Posts Breakeven Q4 Earnings, Beating Estimates by 100% as Revenue Grows 34.2% YoY to $4.5M 3 days ago York Space Systems (YSS) Posts -$0.24 EPS vs. -$0.18 Est., Revenue Soars to $105.3M 3 days ago Scholastic (SCHL) Q3 Loss Narrows to $0.15/Share vs $0.36 Estimate, Revenue Misses at $329.1M 3 days ago Curis (CRIS) EPS Soars 210.8% to $1.23, But Revenue Plunges 67.1% to $1.1M 3 days ago Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 3 days ago
ADVERTISEMENT
Analysis

Yirendai slips as operational weakness overrides Q4 earnings beat

China-based fintech firm Yirendai (YRD) showed broad-based weakness in the fourth quarter, sending its stock down 3.9% during pre-market trading on Monday. Investors remained unmoved by the adjusted earnings of $1.32 per ADS in Q4, much higher than the street projection of 51 cents per ADS. Hurt by a decline in loan origination volume, total […]

March 25, 2019 2 min read
Alphastreet Vertex Pharma Q4 2025 Earnings Results

China-based fintech firm Yirendai (YRD) showed broad-based weakness in the fourth quarter, sending its stock down 3.9% during pre-market trading on Monday. Investors remained unmoved by the adjusted earnings of $1.32 per ADS in Q4, much higher than the street projection of 51 cents per ADS. Hurt by a decline in loan origination volume, total […]

China-based fintech firm Yirendai (YRD) showed broad-based weakness in the fourth quarter, sending its stock down 3.9% during pre-market trading on Monday. Investors remained unmoved by the adjusted earnings of $1.32 per ADS in Q4, much higher than the street projection of 51 cents per ADS.

Hurt by a decline in loan origination volume, total net revenue in the fourth quarter tumbled 30% to $184.8 million.

The company facilitated $1.217 billion worth of loans during the quarter through its online market place, over 31% of which were generated by repeat borrowers. The amount of loan facilitated represents a 38% decline compared to last year.

YRD stock has wiped out over 70% of its value in the trailing 52 weeks. Since the beginning of this year, though, it has recovered somewhat and has gained 6.5%.

READ: NOKIA SHARES PLUNGE AFTER COMPANY WARNS OF COMPLIANCE ISSUES

CEO Yihan Fang said, “Demand for our wealth management product continues to be strong, close to half a million retail investors chose to invest in our platform this year despite volatilities in the industry and we continue to see average AUM per investor increasing.”

“Going into 2019,” CFO Dennis Cong said,  “we will maintain focused on continual diversification in funding sources, expanding our loan product mix as well as enhancing our risk management strategies to support our credit and wealth management business growth.”

Earnings Calendar: Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT